DNA repair germline pathogenic mutation associations with treatment duration and family history in prostate cancer.

被引:0
|
作者
Vu, James
Moses, Marcus Marie
Ranasinghe, Lahiru
Cotogno, Patrick
Manogue, Charlotte
Lewis, Brian E.
Layton, Jodi Lyn
Sartor, A. Oliver
Ledet, Elisa
机构
[1] Tulane Univ, New Orleans, LA 70118 USA
[2] Tulane Univ, Ctr Canc, New Orleans, LA 70118 USA
[3] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[4] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Med Sch, New Orleans, LA USA
关键词
D O I
10.1200/JCO.2019.37.7_suppl.245
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
245
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Germline pathologic mutations and cancer family history in prostate cancer patients.
    Moses, Marcus Marie
    Ledet, Elisa
    Ernst, Emma M.
    Cotogno, Patrick
    Schiff, Joshua
    Lewis, Brian E.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Enrichment of germline DNA-repair gene mutations in patients with colorectal cancer.
    Aldubayan, Saud H.
    Giannakis, Marios
    Moore, Nathanael
    Mu, Xinmeng Jasmine
    Han, G. Celine
    Nishihara, Reiko
    Qian, Zhi Rong
    Liu, Li
    Ogino, Shuji
    Garraway, Levi A.
    Fuchs, Charles S.
    Van Allen, Eliezer Mendel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
    Economides, Minas P.
    Nakazawa, Mari
    Lee, Jonathan
    Hollifield, Lucas
    Balar, Arjun Vasant
    Antonarakis, Emmanuel S.
    Wise, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [34] Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
    Economides, Minas P.
    Lee, Jonathan
    Li, Xiaochun
    Nakazawa, Mari
    Hollifield, Lucas
    Sarfaty, Michal
    Goldberg, Judith D.
    Antonarakis, Emmanuel S.
    Wise, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [35] 3. Duration of androgen suppression in the treatment of prostate cancer.
    Kate Linton and James Catto University of Sheffield
    United Kingdom
    中国肿瘤临床, 2010, 37 (06) : 365 - 365
  • [36] Combined effect of a prostate cancer polygenic risk score and germline pathogenic variants in DNA damage repair genes on prostate cancer risk in men of African ancestry
    Hughley, Raymond W.
    Darst, Burcu F.
    Matejcic, Marco
    Patel, Yesha
    Lilyquist, Jenna
    Hart, Steven N.
    Polley, Eric C.
    Xia, Lucy
    Sheng, Xin
    Lubmawa, Alexander
    Ingles, Sue A.
    Wilkens, Lynne
    Marchand, Loic L.
    Watya, Stephen
    Couch, Fergus J.
    Conti, David V.
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [37] Inherited pathologic mutations and family history in patients with prostate cancer.
    Lin, Shuwen
    Ledet, Elisa M.
    Schiff, Joshua
    Ernst, Emma M.
    Garvey, Cathryn E.
    Lewis, Brian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [38] Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants
    Fasulo, V.
    Buffi, N. M.
    Casale, P.
    Saita, A.
    Hurle, R.
    Finocchiaro, A.
    Aljoulani, M.
    Paciotti, M.
    Asselta, R.
    Solda, G.
    De Simone, I.
    Colombo, P.
    Cieri, M.
    Maura, F.
    Cavalli, P.
    Lughezzani, G.
    Lazzeri, M.
    EUROPEAN UROLOGY, 2024, 85 : S1604 - S1604
  • [39] Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer
    Zhang, Tingwei
    Wei, Yu
    Hong, Boon Hao
    Sumiyoshi, Takayuki
    Ong, Enya Hui Wen
    Zeng, Hao
    Li, Yonghong
    Ng, Chi-Fai
    Pan, Jian
    Fang, Bangwei
    Wang, Beihe
    Wu, Junlong
    Wang, Hongkai
    Akamatsu, Shusuke
    Chua, Melvin Lee Kiang
    Ye, Dingwei
    Zhu, Yao
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (09):
  • [40] Germline mutation landscape of DNA damage repair genes in Oriental pancreatic cancer
    Guo, Shiwei
    Jiang, Lisha
    Shi, Xiaohan
    Gao, Suizhi
    Li, Bo
    Lin, Ling
    Yu, Jun
    Jin, Gang
    CANCER RESEARCH, 2020, 80 (16)